Key Documents

View All Documentation

Y0002361

Saxagliptin

Name: Saxagliptin
Brand: SUPELCO

for system suitability CRS, European Pharmacopoeia (EP) Reference Standard

Synonym(s):

Saxagliptin hydrate, (S)-3-Hydroxyadamantylglycine-L-cis-4,5-methanoprolinenitrile hydrate, BMS 477118, BMS 477118-11, BMS-477118, BMS-477118-11, BMS477118, BMS477118-11

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):

C₁₈H₂₅N₃O₂ · H₂O

CAS Number:

945667-22-1

Molecular Weight:

333.43

NACRES:

NA.24

UNSPSC Code:

41116107

Technical Service

Need help? Our team of experienced scientists is here for you.

Let Us Assist

Properties

grade

pharmaceutical primary standard

API family

saxagliptin

manufacturer/tradename

EDQM

application(s)

pharmaceutical

storage temp.

2-8°C

SMILES string

OC12CC([C@@H](C(N3[C@@H](C[C@]4([C@@]3(C4)[H])[H])C#N)=O)N)(CC(C5)C2)CC5C1.O

InChI

1S/C18H25N3O2.H2O/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17;/h10-15,23H,1-7,9,20H2;1H2/t10?,11?,12-,13+,14+,15-,17?,18?;/m1./s1

InChI key

AFNTWHMDBNQQPX-NHKADLRUSA-N

Description

General description

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Application

Saxagliptin EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Biochem/physiol Actions

Orally active, highly potent & long-acting dipeptidyl peptidase IV (DPP-IV) inhibitor with therapeutic efficacy against type II diabetes in vivo.

Saxagliptin (BMS-477118) is an orally active, highly potent and long-acting dipeptidyl peptidase IV inhibitor (human DPP-IV Ki = 0.9 nM; plasma DDP-IV inhibition = 87% 0.5-4h post 4 μmol/kg po. in normal rats) with therapeutic efficacy against type 2 diabetes in vivo (plasma glucose clearance = 28/43/61% post 0.3/1.0/3.0 μmol/kg po. in Zucker fa/fa rats).

Packaging

Unit quantity: 1.082mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Other Notes

Sales restrictions may apply.

Still not finding the right product?

Explore all of our products under Saxagliptin

pictograms

GHS08

signalword

Danger

hcodes

H317,H334,H361fd,H372

pcodes

P202 - P260 - P264 - P280 - P302 + P352 - P308 + P313

Hazard Classifications

Repr. 2 - Resp. Sens. 1 - Skin Sens. 1 - STOT RE 1

Storage Class

6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c